This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998; 89: 547-51. doi: 10.3171/jns.1998.89.4.0547BuninGRSurawiczTSWitmanPAPreston-MartinSDavisFBrunerJMThe descriptive epidemiology of craniopharyngiomaJ Neurosurg1998895475110.3171/jns.1998.89.4.05479761047Open DOISearch in Google Scholar
Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, Kristensen LO, Astrup J, Jorgensen JO, et al. Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol 2011; 104: 755-63. doi: 10.1007/s11060-011-0540-6NielsenEHFeldt-RasmussenUPoulsgaardLKristensenLOAstrupJJorgensenJOIncidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adultsJ Neurooncol20111047556310.1007/s11060-011-0540-621336771Open DOISearch in Google Scholar
Ostrom QT, Gittleman H, Liao P, Vecchione Koval T, Wolinsky Y, Kruchko C, et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol 2017; 19(Suppl. 5): 1-88. doi: 10.1093/neuonc/nox158OstromQTGittlemanHLiaoPVecchioneKoval TWolinskyYKruchkoCCBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014Neuro Oncol201719Suppl. 518810.1093/neuonc/nox158569314229117289Open DOISearch in Google Scholar
Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013. Neuro Oncol 2016; 18: 1-75. doi: 10.1093/neuonc/now207OstromQTGittlemanHXuJKromerCWolinskyYKruchkoCCBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013Neuro Oncol20161817510.1093/neuonc/now207848356928475809Open DOISearch in Google Scholar
Thapar, K, Kovacs K. Neoplasms of the sellar region. Russell and Rubinstein’s Pathology of Tumors of the Nervous System, 6th Edn. 1998: 629-80.ThaparKKovacsKNeoplasms of the sellar region. Russell and Rubinstein’s Pathology of Tumors of the Nervous System6th Edn199862980Search in Google Scholar
Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER. Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus 2010; 28: E4. doi: 10.3171/2010.2.FOCUS09318ZadaGLinNOjerholmERamkissoonSLawsERCraniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationshipsNeurosurg Focus201028E410.3171/2010.2.FOCUS0931820367361Open DOISearch in Google Scholar
Pascual JM, Prieto R, Rosdolsky M, Strauss S, Castro I, Verena D. Cystic tumors of the pituitary infundibulum : seminal autopsy specimens (1899 to 1904) that allowed clinical-pathological craniopharyngioma characterization. Pituitary 2018; 21: 393-405. doi:10.1007/s11102-018-0889-zPascualJMPrietoRRosdolskyMStraussSCastroIVerenaDCystic tumors of the pituitary infundibulum : seminal autopsy specimens (1899 to 1904) that allowed clinical-pathological craniopharyngioma characterizationPituitary20182139340510.1007/s11102-018-0889-z29680871Open DOISearch in Google Scholar
Wijnen M, Van Den Heuvel-Eibrink MM, Janssen JAMJL, Catsman-Berrevoets CE, Michiels EMC, Van Veelen-Vincent MLC, et al. Very long-Term sequelae of craniopharyngioma. Eur J Endocrinol 2017; 176: 755-67. doi: 10.1530/EJE-17-0044WijnenMVan Den Heuvel-EibrinkMMJanssenJAMJLCatsman-BerrevoetsCEMichielsEMCVanVeelen-Vincent MLCVery long-Term sequelae of craniopharyngiomaEur J Endocrinol20171767556710.1530/EJE-17-004428325825Open DOISearch in Google Scholar
Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbüchel AMM, Müller HL. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: Newly reported long-term outcomes. Neuro Oncol 2015; 17: 1029-38. doi: 10.1093/neuonc/nov044SterkenburgASHoffmannAGebhardtUWarmuth-MetzMDaubenbüchelAMMMüllerHLSurvival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: Newly reported long-term outcomesNeuro Oncol20151710293810.1093/neuonc/nov044565435425838139Open DOISearch in Google Scholar
Erfurth EM, Holmer H, Fjalldal SB. Mortality and morbidity in adult craniopharyngioma. Pituitary 2013; 16: 46-55. doi: 10.1007/s11102-012-0428-2ErfurthEMHolmerHFjalldalSBMortality and morbidity in adult craniopharyngiomaPituitary201316465510.1007/s11102-012-0428-222961634Open DOISearch in Google Scholar
Müller HL, Merchant TE, Puget S, Martinez-Barbera JP. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol 2017; 13: 299-312. doi: 10.1038/nrendo.2016.217MüllerHLMerchantTEPugetSMartinez-BarberaJPNew outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngiomaNat Rev Endocrinol20171329931210.1038/nrendo.2016.21728155902Open DOISearch in Google Scholar
Heinks K, Boekhoff S, Hoffmann A, Warmuth-Metz M, Eveslage M, Peng J, et al. Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007. Endocrine 2018; 59: 364-372. doi: 10.1007/s12020-017-1489-9HeinksKBoekhoffSHoffmannAWarmuth-MetzMEveslageMPengJQuality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007Endocrine20185936437210.1007/s12020-017-1489-929230635Open DOISearch in Google Scholar
Karavitaki N, Brufani C, Warner JT, Adams CBT, Richards P, Ansorge O, et al. Craniopharyngiomas in children and adults: Systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 2005; 62: 397-409. doi: 10.1111/j.1365-2265.2005.02231.xKaravitakiNBrufaniCWarnerJTAdamsCBTRichardsPAnsorgeOCraniopharyngiomas in children and adults: Systematic analysis of 121 cases with long-term follow-upClin Endocrinol (Oxf)20056239740910.1111/j.1365-2265.2005.02231.x15807869Open DOISearch in Google Scholar
Muller HL. Craniopharyngeoma - a chronic disease. Swiss Med Wkly 2018; 148: w14548. doi: 10.4414/smw.2017.14548MullerHLCraniopharyngeoma - a chronic diseaseSwiss Med Wkly2018148w1454810.4414/smw.2017.14548Open DOISearch in Google Scholar
Schoenfeld A, Pekmezci M, Barnes MJ, Tihan T, Gupta N, Lamborn KR, et al. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neurooncol 2012; 8: 133-9. doi: 10.1007/s11060-012-0806-7SchoenfeldAPekmezciMBarnesMJTihanTGuptaNLambornKRThe superiority of conservative resection and adjuvant radiation for craniopharyngiomasJ Neurooncol20128133910.1007/s11060-012-0806-7387915422350375Open DOISearch in Google Scholar
Hoffmann A, Warmuth-Metz M, Gebhardt U, Müller H. Childhood Craniopharyngioma – Changes of Treatment Strategies in the Trials KRANIOPHARYNGEOM 2000/2007. Klin Padiatr 2014; 226: 161-8. doi:10.1055/s-0034-1368785HoffmannAWarmuth-MetzMGebhardtUMüllerHChildhood Craniopharyngioma – Changes of Treatment Strategies in the Trials KRANIOPHARYNGEOM 2000/2007Klin Padiatr2014226161810.1055/s-0034-136878524819386Open DOISearch in Google Scholar
Ajithkumar T, Mazhari AL, Stickan-Verfürth M, Kramer PH, Fuentes CS, Lambert J, et al. Proton Therapy for Craniopharyngioma — An Early Report from a Single European Centre. Clin Oncol 2018; 30: 307-16. doi: 10.1016/j. clon.2018.01.012AjithkumarTMazhariALStickan-VerfürthMKramerPHFuentesCSLambertJProton Therapy for Craniopharyngioma — An Early Report from a Single European CentreClin Oncol2018303071610.1016/j.clon.2018.01.01229459099Open DOISearch in Google Scholar
Kendall-Taylor P, Jönsson PJ, Abs R, Erfurth EM, Koltowska-Häggström M, Price DA, et al. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 2005; 152: 557-67. doi: 10.1530/eje.1.01877Kendall-TaylorPJönssonPJAbsRErfurthEMKoltowska-HäggströmMPriceDAThe clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngiomaEur J Endocrinol20051525576710.1530/eje.1.0187715817911Open DOISearch in Google Scholar
Wijnen M, Olsson DS, Van Den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, Van Der Lely AJ, et al. The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up. Eur J Endocrinol 2018; 178: 11-22. doi: 10.1530/EJE-17-0387WijnenMOlssonDSVan Den Heuvel-EibrinkMMHammarstrandCJanssenJAMJLVan Der LelyAJThe metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-upEur J Endocrinol2018178112210.1530/EJE-17-038728882980Open DOISearch in Google Scholar
Andereggen L, Hess B, Andres RH, El-Koussy M, Mariani L, Raabe A, et al. A ten-year follow-up study of treatment outcome of craniopharyngiomas. Swiss Med Wkly 2018; 148: 1-8. doi: 10.4414/smw.2017.14521AndereggenLHessBAndresRHEl-KoussyMMarianiLRaabeAA ten-year follow-up study of treatment outcome of craniopharyngiomasSwiss Med Wkly20181481810.4414/smw.2017.14521Open DOISearch in Google Scholar
Tan TSE, Patel L, Gopal-Kothandapani JS, Ehtisham S, Ikazoboh EC, Hayward R, et al. The neuroendocrine sequelae of paediatric craniopharyngioma: A 40-year meta-data analysis of 185 cases from three UK centres. Eur J Endocrinol 2017; 176: 359-69. doi: 10.1530/EJE-16-0812TanTSEPatelLGopal-KothandapaniJSEhtishamSIkazobohECHaywardRThe neuroendocrine sequelae of paediatric craniopharyngioma: A 40-year meta-data analysis of 185 cases from three UK centresEur J Endocrinol20171763596910.1530/EJE-16-081228073908Open DOISearch in Google Scholar
Bosnjak R, Benedicic M, Vittori A. Early outcome in endoscopic extended endonasal approach for removal of supradiaphragmatic craniopharyngiomas: A case series and a comprehensive review. Radiol Oncol 2013; 47: 266-79. doi: 10.2478/raon-2013-0036BosnjakRBenedicicMVittoriAEarly outcome in endoscopic extended endonasal approach for removal of supradiaphragmatic craniopharyngiomas: A case series and a comprehensive reviewRadiol Oncol2013472667910.2478/raon-2013-0036379488324133392Open DOISearch in Google Scholar
Brastianos PK, Shankar GM, Gill CM, Taylor-Weiner A, Nayyar N, Panka, DJ, et al. Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. J Natl Cancer Inst 2016; 108: 1-5. doi: 10.1093/jnci/djv310BrastianosPKShankarGMGillCMTaylor-WeinerANayyarNPankaDJDramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted TherapyJ Natl Cancer Inst20161081510.1093/jnci/djv310486241726498373Open DOISearch in Google Scholar
Himes BT, Ruff MW, Gompel JJ Van, Park SS, Galanis E, Kaufmann TJ, et al. Recurrent papillary craniopharyngioma with Dabrafenib: case report. J Neurosurg 2018; 1: 1-5. doi: 10.3171/2017.11.JNS172373HimesBTRuffMWGompelJJ VanParkSSGalanisEKaufmannTJRecurrent papillary craniopharyngioma with Dabrafenib: case reportJ Neurosurg201811510.3171/2017.11.JNS17237329701552Open DOISearch in Google Scholar
Hoffmann A, Boekhoff S, Gebhardt U, Sterkenburg AS, Daubenbüchel AMM, Eveslage M, et al. History before diagnosis in childhood craniopharyngioma: Associations with initial presentation and long-term prognosis. Eur J Endocrinol 2015; 173: 853-62. doi: 10.1530/EJE-15-0709HoffmannABoekhoffSGebhardtUSterkenburgASDaubenbüchelAMMEveslageMHistory before diagnosis in childhood craniopharyngioma: Associations with initial presentation and long-term prognosisEur J Endocrinol20151738536210.1530/EJE-15-070926392473Open DOISearch in Google Scholar
Mortini P, Losa M, Pozzobon G, Barzaghi R, Riva M, Acerno S, et al. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg 2011; 114: 1350-9. doi: 10.3171/2010.11.JNS10670MortiniPLosaMPozzobonGBarzaghiRRivaMAcernoSNeurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case seriesJ Neurosurg20111141350910.3171/2010.11.JNS1067021214336Open DOISearch in Google Scholar
Crotty TB, Scheithauer BW, Young WF, Davis DH, Shaw EG, Miller GM, et al. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 1995; 83: 206-14. doi: 10.3171/jns.1995.83.2.0206CrottyTBScheithauerBWYoungWFDavisDHShawEGMillerGMPapillary craniopharyngioma: a clinicopathological study of 48 casesJ Neurosurg1995832061410.3171/jns.1995.83.2.02067616262Open DOISearch in Google Scholar
Müller HL. Hypothalamic involvement in craniopharyngioma—Implications for surgical, radiooncological, and molecularly targeted treatment strategies. Pediatr Blood Cancer 2018; 65: e26936. doi: 10.1002/pbc.26936MüllerHLHypothalamic involvement in craniopharyngioma—Implications for surgical, radiooncological, and molecularly targeted treatment strategiesPediatr Blood Cancer201865e2693610.1002/pbc.2693629286573Open DOISearch in Google Scholar
Roth CL, Eslamy H, Werny D, Elfers C, Shaffer ML, Pihoker C, et al. Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity. Obesity 2015; 23: 1226-33. doi: 10.1002/oby.21067RothCLEslamyHWernyDElfersCShafferMLPihokerCSemiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesityObesity20152312263310.1002/oby.21067502959925884561Open DOISearch in Google Scholar
Mortini P, Gagliardi F, Bailo M, Spina A, Parlangeli A, Falini A, et al. Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas. Endocrine 2016; 51: 148-62. doi: 10.1007/s12020-015-0683-xMortiniPGagliardiFBailoMSpinaAParlangeliAFaliniAMagnetic resonance imaging as predictor of functional outcome in craniopharyngiomasEndocrine2016511486210.1007/s12020-015-0683-x26179178Open DOISearch in Google Scholar
Müller HL. Craniopharyngioma and hypothalamic injury: Latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes 2016; 23: 81-9. doi: 10.1097/MED.0000000000000214MüllerHL.Craniopharyngioma and hypothalamic injury: Latest insights into consequent eating disorders and obesityCurr Opin Endocrinol Diabetes Obes20162381910.1097/MED.0000000000000214470087726574645Open DOISearch in Google Scholar
Pascual JM, Prieto R, Carrasco R, Barrios L. Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis. J Neurosurg 2013; 119: 381-405. doi: 10.3171/2013.1.JNS111722PascualJMPrietoRCarrascoRBarriosLDisplacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosisJ Neurosurg201311938140510.3171/2013.1.JNS11172223540270Open DOISearch in Google Scholar
Zoicas F, Schöfl C. Craniopharyngioma in Adults. Front Endocrinol (Lausanne) 2012; 3: 46. doi: 10.3389/fendo.2012.00046ZoicasFSchöflCCraniopharyngioma in AdultsFront Endocrinol (Lausanne)201234610.3389/fendo.2012.00046335609722654868Open DOISearch in Google Scholar
Amelot A, Borha A, Calmon R, Barbet P, Puget S. Child dermoid cyst mimicking a craniopharyngioma: the benefit of MRI T2-weighted diffusion sequence. Child’s Nerv Syst 2018; 34: 359-62. doi: 10.1007/s00381-017-3602-zAmelotABorhaACalmonRBarbetPPugetSChild dermoid cyst mimicking a craniopharyngioma: the benefit of MRI T2-weighted diffusion sequenceChild’s Nerv Syst2018343596210.1007/s00381-017-3602-z28921047Open DOISearch in Google Scholar
Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg Pediatr 2007; 106: 3-12. doi: 10.3171/ped.2007.106.1.3PugetSGarnettMWrayAGrillJHabrandJLBodaertNPediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvementJ Neurosurg Pediatr200710631210.3171/ped.2007.106.1.317233305Open DOISearch in Google Scholar
Elowe-Gruau E, Beltrand J, Brauner R, Pinto G, Samara-Boustani D, Thalassinos C, et al. Childhood craniopharyngioma: Hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab 2013; 98: 2376-82. doi: 10.1210/jc.2012-3928Elowe-GruauEBeltrandJBraunerRPintoGSamara-BoustaniDThalassinosCChildhood craniopharyngioma: Hypothalamus-sparing surgery decreases the risk of obesityJ Clin Endocrinol Metab20139823768210.1210/jc.2012-392823633208Open DOISearch in Google Scholar
Weiner HL, Wisoff JH, Rosenberg ME, Kupersmith MJ, Cohen H, Zagzag D, et al. Craniopharyngiomas: A Clinicopathological Analysis of Factors Predictive of Recurrence and Functional Outcome. Neurosurgery 1994; 35: 1001-11. http://dx.doi.org/10.1227/00006123-199412000-00001WeinerHLWisoffJHRosenbergMEKupersmithMJCohenHZagzagDCraniopharyngiomas: A Clinicopathological Analysis of Factors Predictive of Recurrence and Functional OutcomeNeurosurgery199435100111http://dx.doi.org/10.1227/00006123-199412000-0000110.1097/00006123-199412000-00001Search in Google Scholar
Müller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, et al. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: Results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol 2011; 165: 17-24. doi: 10.1530/EJE-11-0158MüllerHLGebhardtUTeskeCFaldumAZwienerIWarmuth-MetzMPost-operative hypothalamic lesions and obesity in childhood craniopharyngioma: Results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-upEur J Endocrinol2011165172410.1530/EJE-11-015821490122Open DOISearch in Google Scholar
Gu Y, Zhang X. Letter to the Editor: Mammillary body angle and craniopharyngioma. J Neurosurg 2014; 120: 1241-5. doi: 10.3171/2013.11.JNS132343GuYZhangXLetter to the Editor: Mammillary body angle and craniopharyngiomaJ Neurosurg20141201241510.3171/2013.11.JNS13234324527817Open DOISearch in Google Scholar
Coury JR, Davis BN, Koumas CP, Manzano GS, Dehdashti AR. Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review. Neurosurg Rev 2018. doi: 10.1007/s10143-018-0978-5CouryJRDavisBNKoumasCPManzanoGSDehdashtiARHistopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic reviewNeurosurg Rev201810.1007/s10143-018-0978-529666970Open DOISearch in Google Scholar
Karavitaki N, Cudlip S, Adams CB, and Wass JA. Craniopharyngiomas. Endocr Rev 2006; 27: 371-97. doi: 10.1210/er.2006-0002KaravitakiNCudlipSAdamsCBWassJACraniopharyngiomasEndocr Rev2006273719710.1210/er.2006-000216543382Open DOISearch in Google Scholar
Clark AJ, Cage TA, Aranda D, Parsa AT, Sun PP, Auguste KI, et al. A systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngioma. Child’s Nerv Syst 2013; 29: 231-8. doi: 10.1007/s00381-012-1926-2ClarkAJCageTAArandaDParsaATSunPPAugusteKIA systematic review of the results of surgery and radiotherapy on tumor control for pediatric craniopharyngiomaChild’s Nerv Syst201329231810.1007/s00381-012-1926-2Open DOISearch in Google Scholar
Kiehna EN, Merchant TE. Radiation therapy for pediatric craniopharyngioma. Neurosurg Focus 2010; 28: E10. doi: 10.3171/2010.1.FOCUS09297KiehnaENMerchantTERadiation therapy for pediatric craniopharyngiomaNeurosurg Focus201028E1010.3171/2010.1.FOCUS09297Open DOISearch in Google Scholar
O’steen L, Indelicato DJ. Advances in the management of craniopharyngioma. F1000Research 2018; 7: 1632. doi:10.12688/f1000research.15834.1O’steenLIndelicatoDJAdvances in the management of craniopharyngiomaF1000Research20187163210.12688/f1000research.15834.1Open DOISearch in Google Scholar
Kortmann RD. Different Approaches in Radiation Therapy of Craniopharyngioma. Front Endocrinol (Lausanne) 2011; 2: 100. doi: 10.3389/fendo.2011.00100KortmannRDDifferent Approaches in Radiation Therapy of CraniopharyngiomaFront Endocrinol (Lausanne)2011210010.3389/fendo.2011.00100Open DOISearch in Google Scholar
Bishop AJ, Greenfield B, Mahajan A, Paulino AC, Okcu MF, Allen, PK, et al. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: Multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys 2014; 90: 354-61. doi: 10.1016/j.ijrobp.2014.05.051BishopAJGreenfieldBMahajanAPaulinoACOkcuMFAllenPKProton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: Multi-institutional analysis of outcomes, cyst dynamics, and toxicityInt J Radiat Oncol Biol Phys2014903546110.1016/j.ijrobp.2014.05.051Open DOISearch in Google Scholar
Harrabi SB, Adeberg S, Welzel T, Rieken S, Habermehl D, Debus J, et al. Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects. Radiat Oncol 2014; 9: 203. doi: 10.1186/1748-717X-9-203HarrabiSBAdebergSWelzelTRiekenSHabermehlDDebusJLong term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effectsRadiat Oncol2014920310.1186/1748-717X-9-203Open DOISearch in Google Scholar
Beltran C, Roca M, Merchant TE. On the Benefits and Risks of Proton Therapy in Pediatric Craniopharyngioma. Int J Radiat Oncol 2012; 82: 281-7. doi: 10.1016/j.ijrobp.2011.01.005BeltranCRocaMMerchantTEOn the Benefits and Risks of Proton Therapy in Pediatric CraniopharyngiomaInt J Radiat Oncol201282281710.1016/j.ijrobp.2011.01.005Open DOISearch in Google Scholar
Regine WF, Kramer S. Pediatric craniopharyngiomas: Long term results of combined treatment with surgery and radiation. Int J Radiat Oncol 1992; 24: 611-17. doi: 10.1016/0360-3016(92)90705-MRegineWFKramerSPediatric craniopharyngiomas: Long term results of combined treatment with surgery and radiationInt J Radiat Oncol1992246111710.1016/0360-3016(92)90705-MOpen DOISearch in Google Scholar
Winkfield KM, Linsenmeier C, Yock TI, Grant PE, Yeap BY, Butler WE, et al. Surveillance of Craniopharyngioma Cyst Growth in Children Treated With Proton Radiotherapy Int J Radiat Oncol 2009; 73: 716-21. doi: https://doi.org/10.1016/j.ijrobp.2008.05.010WinkfieldKMLinsenmeierCYockTIGrantPEYeapBYButlerWESurveillance of Craniopharyngioma Cyst Growth in Children Treated With ProtonRadiotherapy Int J Radiat Oncol20097371621https://doi.org/10.1016/j.ijrobp.2008.05.01010.1016/j.ijrobp.2008.05.01018676089Search in Google Scholar
Losa M, Pieri V, Bailo M, Gagliardi F, Barzaghi LR, Gioia L, et al. Single fraction and multisession Gamma Knife radiosurgery for craniopharyngioma. Pituitary 2018; 21: 499-506. doi: 10.1007/s11102-018-0903-5LosaMPieriVBailoMGagliardiFBarzaghiLRGioiaLSingle fraction and multisession Gamma Knife radiosurgery for craniopharyngiomaPituitary20182149950610.1007/s11102-018-0903-530043097Open DOISearch in Google Scholar
Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrübl F, et al. Common mutations of β-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 2005; 109: 589-97. doi: 10.1007/s00401-005-1004-xBusleiRNoldeMHofmannBMeissnerSEyupogluIYSiebzehnrüblFCommon mutations of β-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar regionActa Neuropathol20051095899710.1007/s00401-005-1004-x15891929Open DOISearch in Google Scholar
Pekmezci M, Louie J, Gupta N, Bloomer MM, Tihan T. Clinicopathological characteristics of adamantinomatous and papillary craniopharyngiomas: University of California, San Francisco experience 1985-2005. Neurosurgery 2010; 67: 1341-9. doi: 10.1227/NEU.0b013e3181f2b583PekmezciMLouieJGuptaNBloomerMMTihanTClinicopathological characteristics of adamantinomatous and papillary craniopharyngiomas: University of California, San Francisco experience 1985-2005Neurosurgery2010671341910.1227/NEU.0b013e3181f2b58320871436Open DOISearch in Google Scholar
Prieto R, Pascual JM. Can tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overview. Pituitary 2018; 21: 431-42. doi: 10.1007/s11102-018-0890-6PrietoRPascualJMCan tissue biomarkers reliably predict the biological behavior of craniopharyngiomas? A comprehensive overviewPituitary2018214314210.1007/s11102-018-0890-629700680Open DOISearch in Google Scholar
Apps JR, Martinez-Barbera JP. Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice. Neurosurg Focus 2016; 41: E4. doi: 10.3171/2016.8.FOCUS16307AppsJRMartinez-BarberaJPMolecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practiceNeurosurg Focus201641E410.3171/2016.8.FOCUS1630727903120Open DOISearch in Google Scholar
Brastianos PK, Taylor-Weiner A, Manley PE, Robert T, Dias-Santagata D, Thorner AR, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 2014; 46: 161-5. doi: 10.1038/ng.2868BrastianosPKTaylor-WeinerAManleyPERobertTDias-SantagataDThornerARExome sequencing identifies BRAF mutations in papillary craniopharyngiomasNat Genet201446161510.1038/ng.2868398231624413733Open DOISearch in Google Scholar
Apps JR, Carreno G, Gonzalez-Meljem JM, Haston S, Guiho R, Cooper JE, et al. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target. Acta Neuropathol 2018; 135: 757-77. doi: 10.1007/s00401-018-1830-2AppsJRCarrenoGGonzalez-MeljemJMHastonSGuihoRCooperJETumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic targetActa Neuropathol20181357577710.1007/s00401-018-1830-2590422529541918Open DOISearch in Google Scholar
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949. doi: 10.1038/nature00766DaviesHBignellGRCoxCStephensPEdkinsSCleggSMutations of the BRAF gene in human cancerNature200241794910.1038/nature0076612068308Open DOISearch in Google Scholar
Larkin SJ, Preda V, Karavitaki N, Grossman A, Ansorge O. BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma. Acta Neuropathol 2014; 127: 927-9. doi: 10.1007/s00401-014-1270-6LarkinSJPredaVKaravitakiNGrossmanAAnsorgeOBRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngiomaActa Neuropathol2014127927910.1007/s00401-014-1270-6402413124715106Open DOISearch in Google Scholar
Bi WL, Larsen AG, Dunn IF. Genomic Alterations in Sporadic Pituitary Tumors. Curr Neurol Neurosci Rep 2018; 18: 4. doi:10.1007/s11910-018-0811-0BiWLLarsenAGDunnIFGenomic Alterations in Sporadic Pituitary TumorsCurr Neurol Neurosci Rep201818410.1007/s11910-018-0811-029396598Open DOISearch in Google Scholar
Aylwin SJB, Bodi I, Beaney R. Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor. Pituitary 2016; 19: 544-6. doi: 10.1007/s11102-015-0663-4AylwinSJBBodiIBeaneyRPronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitorPituitary201619544610.1007/s11102-015-0663-4499687226115708Open DOISearch in Google Scholar
Roque A, Odia Y. BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors. CNS Oncol 2017; 6: 95-9. doi: 10.2217/cns-2016-0034RoqueAOdiaYBRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitorsCNS Oncol2017695910.2217/cns-2016-0034Open DOISearch in Google Scholar
Rostami E, Witt Nyström P, Libard S, Wikström J, Casar-Borota O, Gudjonsson O. Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy. Acta Neurochir (Wien) 2017; 159: 2217-21. doi: 10.1007/s00701-017-3311-0RostamiEWitt NyströmPLibardSWikströmJCasar-BorotaOGudjonssonORecurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapyActa Neurochir (Wien)201715922172110.1007/s00701-017-3311-0Open DOISearch in Google Scholar
Caldarelli M, Massimi L, Tamburrini G, Cappa M, Di Rocco C. Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome. Child’s Nerv Syst 2005; 21: 747-57. doi: 10.1007/s00381-005-1186-5CaldarelliMMassimiLTamburriniGCappaMDi RoccoCLong-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, RomeChild’s Nerv Syst2005217475710.1007/s00381-005-1186-5Open DOISearch in Google Scholar
Müller HL. Childhood craniopharyngioma. Pituitary 2013; 16: 56-67. doi: 10.1007/s11102-012-0401-0MüllerHL.Childhood craniopharyngiomaPituitary201316566710.1007/s11102-012-0401-0Open DOISearch in Google Scholar
Boekhoff S, Bogusz A, Sterkenburg AS, Eveslage M, Müller HL. Long-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo). Eur J Endocrinol 2018; 179: 331-41. doi: 10.1530/EJE-18-0505.BoekhoffSBoguszASterkenburgASEveslageMMüllerHLLong-term effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: results of the German Craniopharyngioma Registry (HIT-Endo)Eur J Endocrinol20181793314110.1530/EJE-18-0505Open DOISearch in Google Scholar
Geffner ME. The growth without growth hormone syndrome. Endocrinol Metab Clin 1996; 25: 649-63. doi: 10.1016/S0889-8529(05)70345-5GeffnerMEThe growth without growth hormone syndromeEndocrinol Metab Clin1996256496310.1016/S0889-8529(05)70345-5Open DOISearch in Google Scholar
Holmer H, Pozarek G, Wirfält E, Popovic V, Ekman B, Björk J, et al. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma J Clin Endocrinol Metab 2010; 95: 5395-402. doi: 10.1210/jc.2010-0993HolmerHPozarekGWirfältEPopovicVEkmanBBjörkJReduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngiomaJ Clin Endocrinol Metab201095539540210.1210/jc.2010-0993Open DOISearch in Google Scholar
Bereket A, Kiess W, Lustig RH, Müller HL, Goldstone AP, Weiss R, et al. Hypothalamic obesity in children. Obes Rev 2012; 13: 780-98. doi: 10.1111/j.1467-789X.2012.01004BereketAKiessWLustigRHMüllerHLGoldstoneAPWeissRHypothalamic obesity in childrenObes Rev2012137809810.1111/j.1467-789X.2012.01004Open DOISearch in Google Scholar
Hoffmann A, Bootsveld K, Gebhardt U, Daubenbüchel AMM, Sterkenburg AS, Müller HL. Nonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngioma. Eur J Endocrinol 2015; 173: 389-97. doi: 10.1530/EJE-15-0422HoffmannABootsveldKGebhardtUDaubenbüchelAMMSterkenburgASMüllerHLNonalcoholic fatty liver disease and fatigue in long-term survivors of childhood-onset craniopharyngiomaEur J Endocrinol20151733899710.1530/EJE-15-0422Open DOISearch in Google Scholar
Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. Lancet 2001; 357: 425-31. doi: 10.1016/S0140-6736(00)04006-XTomlinsonJWHoldenNHillsRKWheatleyKClaytonRNBatesASAssociation between premature mortality and hypopituitarismLancet20013574253110.1016/S0140-6736(00)04006-XOpen DOISearch in Google Scholar
Rosén T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-8. doi: 10.1016/0140-6736(90)91812-ORosénTBengtssonBAPremature mortality due to cardiovascular disease in hypopituitarismLancet1990336285810.1016/0140-6736(90)91812-OOpen DOISearch in Google Scholar
Bülow B, Attewell R, Hagmar L, Malmström P, Nordström CH, Erfurth EM. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab 1998; 83: 3897-904. doi: 10.1210/jc.83.11.3897BülowBAttewellRHagmarLMalmströmPNordströmCHErfurthEMPostoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrenceJ Clin Endocrinol Metab199883389790410.1210/jc.83.11.3897Open DOISearch in Google Scholar
Holmer H, Ekman B, Björk J, Nordstöm CH, Popovic V, Siversson AB, et al. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy. Eur J Endocrinol 2009; 161: 671-9. doi: 10.1530/EJE-09-0449HolmerHEkmanBBjörkJNordstömCHPopovicVSiverssonABHypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapyEur J Endocrinol2009161671910.1530/EJE-09-044919667040Open DOISearch in Google Scholar
Defoort-Dhellemmes S, Moritz F, Bouacha I, Vinchon M. Craniopharyngioma: ophthalmological aspects at diagnosis. J Pediatr Endocrinol Metab 2006; 19(Suppl 1): 321-4. http://europepmc.org/abstract/MED/16700306Defoort-DhellemmesSMoritzFBouachaIVinchonMCraniopharyngioma: ophthalmological aspects at diagnosisJ Pediatr Endocrinol Metab200619Suppl 13214http://europepmc.org/abstract/MED/16700306Search in Google Scholar
Pierre-Kahn A, Recassens C, Pinto G, Thalassinos C, Chokron S, Soubervielle JC, et al. Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood. A prospective series. Child’s Nerv Syst 2005; 21: 817-24. doi: 10.1007/s00381-005-1205-6Pierre-KahnARecassensCPintoGThalassinosCChokronSSoubervielleJCSocial and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood. A prospective seriesChild’s Nerv Syst2005218172410.1007/s00381-005-1205-616049724Open DOISearch in Google Scholar
Riva D, Pantaleoni C, Devoti M, Saletti V, Nichelli F, Giorgi C. Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma. Child’s Nerv Syst 1998; 14: 179-84. doi: 10.1007/s003810050207RivaDPantaleoniCDevotiMSalettiVNichelliFGiorgiCLate neuropsychological and behavioural outcome of children surgically treated for craniopharyngiomaChild’s Nerv Syst1998141798410.1007/s0038100502079660119Open DOISearch in Google Scholar
Özyurt J, Müller HL, Warmuth-Metz M, Thiel CM. Hypothalamic tumors impact gray and white matter volumes in fronto-limbic brain areas. Cortex 2017; 89: 98-110. doi: 10.1016/j.cortex.2017.01.017ÖzyurtJMüllerHLWarmuth-MetzMThielCMHypothalamic tumors impact gray and white matter volumes in fronto-limbic brain areasCortex2017899811010.1016/j.cortex.2017.01.01728259055Open DOISearch in Google Scholar
Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E. Outcome of craniopharyngioma in complications and quality of life. Dev Med Child Neurol 2004; 46: 220-9. doi: 10.1111/j.1469-8749.2004.tb00476.xPorettiAGrotzerMARibiKSchonleEBoltshauserEOutcome of craniopharyngioma in complications and quality of lifeDev Med Child Neurol200446220910.1111/j.1469-8749.2004.tb00476.xOpen DOISearch in Google Scholar
Dekkers OM, Biermasz NR, Smith JWA, Groot LE, Roelfsema F, Romijn, JA, et al. Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 2006; 154: 483-9. doi: 10.1530/eje.1.02114DekkersOMBiermaszNRSmithJWAGrootLERoelfsemaFRomijnJAQuality of life in treated adult craniopharyngioma patientsEur J Endocrinol2006154483910.1530/eje.1.0211416498063Open DOISearch in Google Scholar
Gautier A, Godbout A, Grosheny C, Tejedor I, Coudert M, Courtillot C, et al. Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients. J Clin Endocrinol Metab 2012; 97: 1258-67. doi:10.1210/jc.2011-2817GautierAGodboutAGroshenyCTejedorICoudertMCourtillotCMarkers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patientsJ Clin Endocrinol Metab20129712586710.1210/jc.2011-281722319039Open DOISearch in Google Scholar
van Iersel L, Meijneke RWH, Schouten-van Meeteren AYN, Reneman L, de Win MM, van Trotsenburg ASP, et al. The development of hypothalamic obesity in craniopharyngioma patients: a risk factor analysis in a well-defined cohort. Pediatr Blood Cancer 2018; 65: e26911. doi: 10.1002/pbc.26911van IerselLMeijnekeRWHSchouten-van MeeterenAYNRenemanLde WinMMvan TrotsenburgASPThe development of hypothalamic obesity in craniopharyngioma patients: a risk factor analysis in a well-defined cohortPediatr Blood Cancer201865e2691110.1002/pbc.2691129314661Open DOISearch in Google Scholar
Borrill R, Cheesman E, Stivaros S, Kamaly-Asl ID, Gnanalingham K, Kilday J-P. Papillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literature. Child’s Nerv Syst 2019; 35: 169-73. doi:10.1007/s00381-018-3925-4.BorrillRCheesmanEStivarosSKamaly-AslIDGnanalinghamKKildayJ-PPapillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literatureChild’s Nerv Syst2019351697310.1007/s00381-018-3925-4634115330069716Open DOISearch in Google Scholar
